Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VFO Group was a private assistive technology and accessibility company focused on products and services for people who are blind or have low vision. The company brought together brands including Freedom Scientific, Ai Squared, Optelec, Enhanced Vision, and The Paciello Group to provide screen readers, magnification tools, braille and low-vision hardware, and digital accessibility services. In September 2018, VFO announced a corporate rebranding and changed its name to Vispero. It was not a biotech or pharmaceutical drug developer; rather, it operated in healthcare-adjacent assistive technology and accessibility markets with fully commercialized products and services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VFO Group.